The novel therapy of this peptide represents a exciting advance in the handling of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – resulting in https://tirzepatidepeptide839134.dgbloggers.com/42443411/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment